Complix

Complix

Foundation date

23/06/2008

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Peptides
• #Therapeutics - Proteins

Therapeutic areas

• #Cardiovascular
• #Diseases of the blood and blood-forming organs - immune disorders
• #Infectious and parasitic diseases
• #Neoplasms / cancer / oncology

Complix is a biopharmaceutical company engaged in the discovery and development of Alphabodies™, a revolutionary class of biopharmaceuticals with exceptional properties. Alphabodies™ combine beneficial properties of small molecules with those of antibodies, and can address intracellular as well as extracellular disease targets that are undruggable by antibodies or small chemical drugs. Complix has developed a balanced pipeline of transformative protein therapeutics in oncology, autoimmunity/inflammation and viral diseases.